Skip to main navigation
logo
Menu
  • About
    • Overview
    • History
    • Values
    • Management
    • Board of Directors
    • Diversity & Inclusion
    • Social Community Guidelines
  • Programs
    • Overview
    • Sickle Cell Disease
    •   – Voxelotor
    •   – Inclacumab
    • Presentations and Publications
  • Patients & Physicians
    • GBT's Commitment
    •   – GBT Supported Conferences
    • Sickle Cell Disease Resources
    • Funding and Support
    • Expanded Access Policy
  • Investors

    Header menu

    • Investor Overview
    • Press Releases
    • Events & Presentations
    • Stock Information
    • Analyst Coverage
    • SEC Filings
    • Corporate Governance
    • Investor FAQs
    • E-mail Alerts
    • IR Contact
  • Media
  • Careers
  • Contact
youtube
twitter
linkedin

Investors

IR Contact

IR Contact

Global Blood Therapeutics

171 Oyster Point Blvd., Suite 300
South San Francisco, CA 94080

1-883-GBT-CORP
info@gbt.com

 
Investor inquiries
investor@gbt.com
 
 
Media inquiries
media@gbt.com

Investor Relations

  • Company Overview
  • Press Releases
  • Events & Presentations
  • Stock Information
  • Analyst Coverage
  • SEC Filings
  • Corporate Governance
  • Investor FAQs
  • E-mail Alerts
  • IR Contact

Shareholder Tools

  • Print Page
  • RSS Feeds
  • E-mail Alerts
  • IR Contact
© Global Blood Therapeutics Inc. Home | Privacy Policy